Most employers offer cancer benefits. Almost none cover what happens in the first 30 days after diagnosis when fertility decisions have to be made quickly, and can impact reproductive options often permanently.
Nearly 80,000 young American adults are diagnosed with cancer each year. Fewer than half discuss fertility preservation before treatment begins. That gap doesn't just affect patients; it creates downstream liability for employers through avoidable costs and delayed care, leaving employees to navigate irreversible decisions without support.
Oncofertility, the integration of fertility preservation into cancer care, is one of the fastest-growing gaps in employer benefits, yet remains one of the least understood and least supported areas in employer benefits today.
In this webinar, clinical leaders from Maven and Color share new findings from a national survey of HR and benefits leaders on how employers are approaching oncofertility today and where they're exposed.
You'll leave knowing:
- Why existing cancer and fertility benefits don't add up to coordinated support at the moment it matters most
- What the data shows about where employers understand the risk, and where they don't
- How unmanaged oncofertility drives downstream costs, and what a different approach looks like in practice